达格列净是用于治疗2型糖尿病的SGLT2抑制剂,可用于2型糖尿病患者的辅助饮食和运动,改善血糖控制。通过抑制钠-葡萄糖转运蛋白2(SGLT2),即肾内的一种使葡萄糖被重新吸收到血液中的蛋白质而发挥作用。这使得多余的葡萄糖通过尿液被排除体外,从而在不增加胰岛素分泌的情况下改善血糖控制。
百灵威供应达格列净关键原料及杂质,离子对试剂,顶空试剂、LC-MS试剂等产品,助力企业研发与生产。
| 品名 | CAS | 货号 |
|---|---|---|
| 5-Bromo-2-chlorobenzoic acid, 99% 5-溴-2-氯苯甲酸 , 99% | 21739-92-4 | 128429 |
| (5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone (5-溴-2-氯苯基)(4-乙氧苯基)甲酮 , 95% | 461432-22-4 | 225413 |
| 4-(5-Bromo-2-chlorobenzyl)phenyl Ethyl Ether 4-(2-氯-5-溴苄基)苯乙醚 | 461432-23-5 | SY025637 |
| (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol 2-氯-5-(1-甲氧基-D-吡喃葡萄糖-I-基)-4-乙氧基二苯甲烷 | 714269-57-5 | M263010 |
| Dapagliflozin Hydroxy Impurity 羟基达格列净杂质 | 960404-86-8 | D185555 |
| D-Glucono-1,4-lactone, 95% D-葡萄糖酸-1,4-内酯 , 95% | 1198-69-2 | 2335026 |
| (2-Chloro-5-iodophenyl)(4-ethoxyphenyl)methanone (2-氯-5-碘苯基)(4-乙氧基苯基)甲酮 , 97% | 1103738-26-6 | 519639 |
| (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(hydroxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol (2S,3R,4R,5S,6R)-2-(4-氯-3-((4-乙氧基苯基)(羟基)甲基)苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-5三醇 , 98+% | 1204222-85-4 | Y17914 |
| 4-Chloro-3-(4-ethoxybenzyl)phenol 4-氯-3-(4-乙氧基苄基)苯酚 | 1408077-50-8 | Y17862 |
| (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate (2R,3R,4R,5S,6S)-2-(乙酰氧基甲基)-6-(4-氯-3-(4-甲氧基苄基)苯基)四氢-2H-吡喃-3,4,5-三乙基三乙酸酯 | 872980-38-6 | R40310 |